AKT1 and neoplasm: We found that NS1643 inhibited activation of AKT, indicated by decreased phosphorylation of both AKT on T308 and β-catenin on Ser 552 in cell lines (Fig. 6a) and MDA-MB-231-derived tumor xenografts (Fig. 6b).